Millions of people around the world are still affected by the coronavirus pandemic, also known as COVID-19. As scientists scramble and increase efforts in developing and testing potential treatments and preventative measures, a new study suggests that CBD or cannabis may potentially become a cure for COVID-19.
Forbes reports some scientists are looking into the possibility of CBD becoming a COVID-19 cure or have some health benefits for those who are suffering from severe cases. The researchers then suggested that there are ways that cannabis-derived CBD could help severe coronavirus patients. One of which is the ability to reduce ACE2 expression and pro-inflammatory cytokine production that helps fight the inflammation of the lungs. Another is that it has the potential ability to be an antiviral treatment. However, not many studies have tested these theories.
But recently, the study from researchers at Georgia’s Augusta University suggests that CBD may benefit ARDS, also known as acute respiratory distress syndrome, which happens to be one of the severe symptoms of COVID-19. The researchers tested this theory on mice that were first given a dose of Poly(I:C) to artificially induce ARDS that has similar symptoms to COVID-19 patients. Once the mice were experiencing this syndrome, the researchers then gave them a dose of CBD. They noticed the impact CBD has in treating ARDS, which has resulted in a complete or semi-reversal of symptoms.
“Currently, other than supportive measures, there is no definitive cure for ARDS, illustrating the urgent need for creative and effective therapeutic modalities to treat this complex condition,” said the researchers. However, this study appears to add more weight to the possibility that CBD can be used as a possible cure for this dangerous symptom of COVID-19.
Meanwhile, according to the Russian representative for the World Health Organization Melita Vujnovic, it is possible that the virus may have been dormant all this time before it first broke out in Wuhan, China, in 2019. Chinese scientists, as well as the WHO has been looking into the origins of the virus by partnering to figure out where the virus came from.
Vujnovic explained that the virus was likely present in animals and somehow has passed onto humans. However, it proves difficult to specify when and where this all began.


Jared Isaacman Confirmed as NASA Administrator, Becomes 15th Leader of U.S. Space Agency
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
China vs. NASA: The New Moon Race and What's at Stake by 2030
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
Blue Origin New Glenn Rocket Explodes During Launch Pad Test, Delaying Space Ambitions
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
SpaceX Delays Starship V3 Launch Ahead of Potential Record IPO
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
NIH Infectious Disease Leadership Shake-Up Raises Concerns Amid Ebola, Hantavirus Outbreaks
White House Seeks $1.4 Billion to Combat Growing Ebola Outbreak
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1 



